Prescriber

Prescriber is a United Kingdom journal for healthcare professionals who prescribe medicines, published by Wiley from Chichester, West Sussex. Described by its publisher as the leading United Kingdom journal focusing on prescribing and medicines management, and as the independent voice of the United Kingdom prescribing community, it is a monthly, fully peer-reviewed title covering all areas of therapeutics and prescribing policy. Its readers are the clinicians who decide what the National Health Service prescribes: general practitioners first, alongside pharmacists, nurses and hospital specialists, and the policy-makers who shape prescribing at local and national level. In a health system where medicines are among the largest and fastest-changing areas of spending, Prescriber exists to inform, educate, stimulate and challenge the people responsible for using them well.

A peer-reviewed journal of prescribing and medicines management

Prescriber's scope is defined by practice rather than by a single disease area. Journal listings summarise it as featuring articles on all areas of therapeutics and prescribing policy, fully peer reviewed, with content relevant to all prescribers and prescribing policy-makers including GPs, pharmacists, nurses and hospital specialists. That breadth reflects how prescribing works in modern British healthcare: a GP managing hypertension, diabetes, respiratory disease and mental health in a single clinic, a pharmacist prescriber running a long-term conditions service and a hospital specialist initiating high-cost therapies all face the same underlying questions of evidence, safety, cost-effectiveness and patient preference. Prescriber addresses those questions across therapeutic areas, rather than leaving each specialty to its own literature.

Publisher, place and identifiers

Prescriber is published by Wiley, one of the world's largest scholarly and professional publishers, whose United Kingdom offices at The Atrium, Southern Gate, Chichester, West Sussex, match the Chichester location recorded for the title. The journal carries the print ISSN 0959-6682 and electronic ISSN 1931-2253, identifiers that anchor it in library and indexing systems worldwide. It has no sponsoring association affiliation, a point its listings make explicitly and its marketing turns into a virtue: Prescriber presents itself as independent, answerable to its readers and peer reviewers rather than to a professional body's policy line, while still working closely with the clinical communities it serves.

Readership and reach

Wiley's media information for Prescriber gives a clear picture of its scale. The 2024 media guide records 25,000 recipients in print, 16,725 recipients of its eNewsletter and an average of 44,426 monthly pageviews for its digital content. Its listed readership spans general practitioners, hospital doctors, nurses, pharmacists and policy-makers. Those figures describe an influential audience: prescribers collectively control the NHS primary care prescribing budget, in which the largest areas of expenditure recorded in recent national analysis include diabetes medicines at over £1.2 billion a year, anticoagulants at over £800 million and respiratory steroids at over £600 million, with antidepressants, analgesics, antiepileptics and hypertension and heart failure treatments also among the biggest categories. A journal trusted by the clinicians making those decisions is a significant channel for evidence, guidance and, for its commercial partners, communication.

What Prescriber publishes

The journal's content mixes clinical reviews, therapeutics updates, prescribing policy analysis and practical guidance. Articles examine new drugs and new evidence for established ones, compare treatment options within a therapeutic area, and explore the systems around prescribing: formularies, prescribing budgets, medicines optimisation, safety alerts and the implementation of national guidance. Wiley also offers individually tailored, peer-reviewed supplements to support products through their life cycle, a standard feature of medical publishing in which sponsored content is produced to the journal's peer-review standards and clearly framed for readers. Recruitment advertising and digital advertising sit alongside the editorial, reflecting the journal's role as a professional marketplace as well as a clinical resource.

Non-medical prescribing and a widening community

Prescriber's audience has widened with the profession itself. Prescribing in the United Kingdom is no longer the preserve of doctors: nurse, pharmacist, physiotherapist and other allied health prescribers now hold independent prescribing rights after approved education, mapped against a national competency framework for all prescribers. Wiley's own textbook publishing for non-medical prescribing students sits in the same professional world as the journal. Prescriber's explicit inclusion of nurses and pharmacists in its core readership, rather than as an afterthought, reflects this reality, and its articles on prescribing policy speak to a community in which prescribing competence, governance and continuing development are shared concerns across professions working in general practice, community pharmacy, hospitals and integrated care systems.

Safety, quality and the cost of medicines

Two pressures dominate modern prescribing, and both dominate the journal's agenda. The first is safety: adverse drug reactions, interactions, polypharmacy in older people and the deprescribing of medicines whose harms outweigh their benefits are recurring themes in prescribing literature, and a peer-reviewed journal is where clinicians look for balanced assessments when safety signals emerge. The second is value: as specialty and high-cost medicines grow, particularly biologic treatments in oncology and immunology in secondary care, prescribers and policy-makers must weigh clinical benefit against opportunity cost across the whole NHS. Prescriber's combination of therapeutics and policy coverage is designed for exactly that junction, helping readers understand not only whether a medicine works, but whether, where and for whom it should be used.

Digital presence and newsletters

Although rooted in print, Prescriber operates as a digital journal. Its website at prescriber.co.uk carries articles, news and resources between monthly issues, its eNewsletter reaches more than sixteen thousand recipients, and its monthly pageviews show a readership that consults content online as guidance questions arise in clinic. This matters in prescribing, where the useful life of information can be short: a safety alert, a supply shortage or a change in national guidance may require a prescriber to check current thinking immediately rather than wait for the next issue. The print edition remains the curated, peer-reviewed record; the digital channels provide speed, searchability and the alerts that keep a monthly journal relevant every day.

Sister publications and the Wiley portfolio

Prescriber sits within Wiley's wider portfolio of medical and nursing journals and professional titles, which its media guide presents as sister publications offering advertisers and readers routes into adjacent clinical communities. For readers, that portfolio context brings production standards, indexing, archiving and peer-review systems of a major international publisher to a nationally focused title. Wiley's corporate solutions operation works with clients to communicate with Prescriber's engaged and influential health professional audience through advertising, supplements, reprints and digital campaigns, while the journal's editorial independence is maintained through peer review and clear separation of sponsored material, the standard safeguards of reputable medical publishing.

Prescribing in primary care

The journal's heartland remains primary care, where most NHS prescriptions are written and where the batch record for this profile correctly places its focus. General practice prescribers manage the long-term conditions that dominate prescribing spend — diabetes, cardiovascular disease, respiratory disease, pain and mental health — under intense time pressure, with ten-minute consultations and constantly updated guidance. Practical, trustworthy synthesis is therefore the product Prescriber sells: not raw trial data, but expert, peer-reviewed interpretation that a busy GP, practice pharmacist or nurse prescriber can apply the same day. Its coverage of prescribing advice, guideline changes and medicine safety issues reported in its field, such as monitoring requirements for individual drugs and summaries of regulatory letters to healthcare professionals, shows the granular level at which that synthesis operates.

Why Prescriber matters

Every prescription is a clinical decision, a cost and a small act of trust between a patient and the health service. Multiply that by the more than a billion prescription items dispensed in the community in England in a typical year and the scale of Prescriber's subject becomes clear. A monthly, peer-reviewed, independent journal that reaches twenty-five thousand prescribers in print, many thousands more by newsletter and tens of thousands online, that speaks across the medical, nursing and pharmacy professions from its publisher's base in Chichester, plays a quiet but real part in the quality of British healthcare. For clinicians who prescribe, and for the policy-makers who support them, Prescriber remains what it sets out to be: the independent voice of the United Kingdom prescribing community.